| Secondary Acute Myeloid Leukemia investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 72show all (up to 200) |
|---|
| → investigated in trials for | Cytarabinesmall molecule 49 trials (13 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 41 trials (10 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall_molecule 30 trials (7 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 25 trials (11 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 17 trials (12 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 14 trials (2 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Secondary Acute Myeloid Leukemia | 7 | Observed | clinicaltrials | graph → |